Advertise
NEWSLETTER
Jupiter Neurosciences doses...
Cerevance reports Solengepr...
AgelessRx introduces GHK-Cu...
ProMIS appoints new chief c...
Shift uses AI virtual cells...
Jupiter Neurosciences doses...
Cerevance reports Solengepr...
AgelessRx introduces GHK-Cu...
ProMIS appoints new chief c...
Shift uses AI virtual cells...
Mitochondria

Longevity investment: Apollo aims for the moon

CohBar CEO on the development of a “true portfolio” of mitochondria based therapeutics for the treatment of chronic and age-related diseases.

It’s time to sit up and take notice of mitochondria

Mitrix mitochondria

“Whole-body mitochondrial transfusion” start-up lands funding

Mitrix wants to create biobanks of our “young mitochondria” that we can use to help our

Cellvie

Harvard spin-off Cellvie Inc closes $5M seed round

CohBar and NIAID announce that they are set to assess CB5064 Analogues for COVID-19 and respiratory distress treatment.

CohBar announces preclinical collaboration with NIAID

Longevity supplement Mitocholine addresses “brain energy gap” to counteract development of metabolic syndrome and impede onset of dementia.

New Longevity supplement targets cognitive decline

Using optogenetics on gut microbes can promote Longevity.

Gut health shines a light on Longevity

Joined-up thinking and the hallmarks of aging

Mounting evidence shows an important role for calcium and ROS interplay in fine-tuning cellular signalling and physiological responses.

Calcium and ROS crosstalk: a key to extending healthspan?

GDF15 protects from age‐related metabolic phenotypes

GDF15 protects from age‐related metabolic phenotypes

New CRISPR-free gene-editing tool exploits bacterial warfare

Off-patent protein could be a key to Longevity

Researchers use metformin to repair broken cell machinery and drastically lower dangerous inflammation causing inflammaging

Metformin boost for inflammaging research

epigenetic regulators

Two novel anti-aging targets identified

Zombie cells senescence longevity technology

Pathway to Longevity: get rid of zombie cells

Targeting mitochondria to fight aging

Targeting mitochondria to fight aging

Next generation of senescence research

Elysium Health is to study correlations between epigenetic aging and amounts of NAD+ and other biomarkers in a new clinical trial.

Elysium announces epigenetic aging clinical trial

Dr Nir Barzilai: Creating a template for all aging trials

Life extension studies fly the flag for Rapamycin – a clever drug with humble origins – now a US research team is taking matters further.

Taking life-extending drug Rapamycin to the next level

Metformin could limit the health benefits of exercise

Parkinson’s UK charity strikes a £1 million deal partnership with NRG Therapeutics for developing drugs aimed at mitochondria.

Parkinson’s charity backs new biotech NRG Therapeutics

Osteoporosis is a debilitating disease; tackling it on a cellular level could mean a marked improvement in the quality of life for an aging population.

Heathspan boost as researchers find link between mitochondria and osteoporosis

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE

  • $617BN - Annual global revenue by 2045
  • $30BN+ - Invested in under 2 years
  • 3,036 - Therapeutics individually assessed